US Patent Issued to LISCURE BIOSCIENCES on Sept. 29 for "Composition for treatment of autoimmune diseases comprising Lactobacillus sakei or extracellular vesicles derived therefrom as active ingredient" (South Korean Inventor)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,263, issued on Sept. 29, was assigned to LISCURE BIOSCIENCES INC. (Seongnam-si, South Korea).

"Composition for treatment of autoimmune diseases comprising Lactobacillus sakei or extracellular vesicles derived therefrom as active ingredient" was invented by Hwa Sup Chin (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a composition containing Lactobacillus sakei or extracellular vesicles derived therefrom. The present disclosure also relates to a novel Lactobacillus sakei LBML6 strain. The Lactobacillus sakei according to the present disclosure is a strain which has inhibitory activity against TNFA...